Furthermore, the metabolism reprogramming of cancer-associated fibroblasts (CAFs) mediated by exosomal PKM2 results in a shift towards glycolysis, creating an acidic microenvironment that ultimately confers and maintains DDP resistance. This evidence concerns the gene PKM and cancer.